Mukul Agrawal purchased 3,00,000 shares of this Small-Cap Specialty Chemicals Stock; Script surges over 60% from 52-week low!

On Friday, shares of Tatva Chintan Pharma Chem Limited jumped 7 per cent to Rs 1,000.10 per share with an intraday high of Rs 1,062.70 per share and an intraday low of Rs 970 per share. The stock’s 52-week high is Rs 1,174.15 per share and its 52-week low is Rs 610 per share. An ace investor, Mukul Agrawal, purchased 300,000 shares or a 1.28 per cent of this Small-Cap Specialty Chemicals Stock in Q1FY26.

Tatva Chintan Pharma Chem Limited, established in 1996, boasts a diverse product range encompassing 214 items across four key categories, including Structure Directing Agents, Phase Transfer Catalysts, Electrolyte Salts & Others, and Pharmaceuticals & Agrochemicals Intermediates and other Specialty Chemicals, serving a distinguished clientele that includes Laurus Labs Limited, Atul Limited, Asian Paints Limited, SRF Limited, Otsuka Pharmaceutical India Private Limited, Divis Laboratories Limited, Merck Life Science Private Limited, and Navin Fluorine International Limited, all supported by their manufacturing facilities located in Ankleshwar and Dahej SEZ, Gujarat.

The company have a market cap of over Rs 2,300 crore and has been maintaining a healthy dividend payout of 22 per cent. The shares of the company have a PE of 4150x, an ROE of 1 per cent and an ROCE of 1 per cent. The stock is up over 60 per cent from its 52-week low of Rs 610 per share and on July 18, 2025, the shares saw a spurt in volume by more than 7 times.

Disclaimer: The article is for informational purposes only and not investment advice.